{"entity":{"type":"insider","cik":"0001796354","url":"/insider/0001796354","json_url":"/insider/0001796354.json","name":"Column Group IV, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":73,"n_filings":26,"first":"2022-01-26","last":"2026-02-09","span_basis":"filed_date"},"name_variants":[{"name":"Column Group IV, LP","source":"filing","n_filings":26,"first_seen":"2022-01-26","last_seen":"2026-02-09"}],"transactions":[{"id":5958428,"accession":"0001193125-26-043320","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001193125-26-043320","line_url":"/filing/0001193125-26-043320","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Eikon Therapeutics, Inc.","issuer_ticker":"EIKN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_display_name":"Column Group IV GP, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2117760.0,"shares_display":"2,117,760","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":38119680.0,"total_display":"38,119,680.00","total_whole":"38,119,680","shares_owned_after":4312139.0,"shares_owned_after_display":"4,312,139","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider","n_lines":3},{"id":8530681,"accession":"0000950170-23-064854","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-064854","line_url":"/filing/0000950170-23-064854#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; COLUMN GROUP L P; Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG IV GP, LLC","owner_display_name":"COLUMN GROUP GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5840.0,"shares_display":"5,840","price_per_share":0.6211,"price_display":"0.62","price_state":"stated","total_value":3627.224,"total_display":"3,627.22","total_whole":"3,627","shares_owned_after":949862.0,"shares_owned_after_display":"949,862","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":8530677,"accession":"0000950170-23-064854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-064854","line_url":"/filing/0000950170-23-064854#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; COLUMN GROUP L P; Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG IV GP, LLC","owner_display_name":"COLUMN GROUP GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16791.0,"shares_display":"16,791","price_per_share":0.7075,"price_display":"0.71","price_state":"stated","total_value":11879.6325,"total_display":"11,879.63","total_whole":"11,880","shares_owned_after":944022.0,"shares_owned_after_display":"944,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":7987197,"accession":"0000899243-23-003137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-003137","line_url":"/filing/0000899243-23-003137#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III, LP; Column Group IV GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP GP, LP; TCG IV GP, LLC; Column Group IV, LP; Column Group Opportunity III GP, LP","owner_display_name":"Column Group Opportunity III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":176730.0,"shares_display":"176,730","price_per_share":4.9986,"price_display":"5.00","price_state":"stated","total_value":883402.578,"total_display":"883,402.58","total_whole":"883,403","shares_owned_after":927231.0,"shares_owned_after_display":"927,231","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-01","scope":"insider"},{"id":7987193,"accession":"0000899243-23-003137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-003137","line_url":"/filing/0000899243-23-003137#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III, LP; Column Group IV GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP GP, LP; TCG IV GP, LLC; Column Group IV, LP; Column Group Opportunity III GP, LP","owner_display_name":"Column Group Opportunity III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7542.0,"shares_display":"7,542","price_per_share":4.9996,"price_display":"5.00","price_state":"stated","total_value":37706.9832,"total_display":"37,706.98","total_whole":"37,707","shares_owned_after":750501.0,"shares_owned_after_display":"750,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider"},{"id":8350602,"accession":"0000899243-23-002637","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002637","line_url":"/filing/0000899243-23-002637#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP L P; Column Group IV GP, LP; Column Group Opportunity III, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; Column Group Opportunity III GP, LP; COLUMN GROUP GP, LP; TCG IV GP, LLC; COLUMN GROUP III-A, LP","owner_display_name":"COLUMN GROUP L P","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9900.0,"shares_display":"9,900","price_per_share":4.9994,"price_display":"5.00","price_state":"stated","total_value":49494.06,"total_display":"49,494.06","total_whole":"49,494","shares_owned_after":742959.0,"shares_owned_after_display":"742,959","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":8350589,"accession":"0000899243-23-002380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002380","line_url":"/filing/0000899243-23-002380#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group IV, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP","owner_display_name":"Column Group IV GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.996,"price_display":"5.00","price_state":"stated","total_value":2498.0,"total_display":"2,498.00","total_whole":"2,498","shares_owned_after":733059.0,"shares_owned_after_display":"733,059","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-23","scope":"insider"},{"id":8350582,"accession":"0000899243-23-002380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002380","line_url":"/filing/0000899243-23-002380#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group IV, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP","owner_display_name":"Column Group IV GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37639.0,"shares_display":"37,639","price_per_share":4.9976,"price_display":"5.00","price_state":"stated","total_value":188104.6664,"total_display":"188,104.67","total_whole":"188,105","shares_owned_after":732559.0,"shares_owned_after_display":"732,559","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-23","scope":"insider"},{"id":8062095,"accession":"0000899243-23-001855","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001855","line_url":"/filing/0000899243-23-001855#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP L P; Column Group Opportunity III, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group IV GP, LP; COLUMN GROUP GP, LP; TCG IV GP, LLC; Column Group IV, LP; COLUMN GROUP III-A, LP","owner_display_name":"COLUMN GROUP L P","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5378.0,"shares_display":"5,378","price_per_share":4.9466,"price_display":"4.95","price_state":"stated","total_value":26602.8148,"total_display":"26,602.81","total_whole":"26,603","shares_owned_after":694920.0,"shares_owned_after_display":"694,920","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-12","filed_date":"2023-01-17","scope":"insider"},{"id":8720417,"accession":"0000899243-23-001695","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-001695","line_url":"/filing/0000899243-23-001695#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group IV, LP","owner_display_name":"Column Group IV GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":209000.0,"shares_display":"209,000","price_per_share":4.76,"price_display":"4.76","price_state":"stated","total_value":994840.0,"total_display":"994,840.00","total_whole":"994,840","shares_owned_after":689542.0,"shares_owned_after_display":"689,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-12","scope":"insider"},{"id":8720414,"accession":"0000899243-23-001695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-001695","line_url":"/filing/0000899243-23-001695#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group IV, LP","owner_display_name":"Column Group IV GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100070.0,"shares_display":"100,070","price_per_share":4.8418,"price_display":"4.84","price_state":"stated","total_value":484518.926,"total_display":"484,518.93","total_whole":"484,519","shares_owned_after":480542.0,"shares_owned_after_display":"480,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-12","scope":"insider"},{"id":6444408,"accession":"0000899243-22-038466","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-038466","line_url":"/filing/0000899243-22-038466#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Column Group IV GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP GP, LP; Column Group IV, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; TCG IV GP, LLC","owner_display_name":"Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":4.9767,"price_display":"4.98","price_state":"stated","total_value":1493.01,"total_display":"1,493.01","total_whole":"1,493","shares_owned_after":380472.0,"shares_owned_after_display":"380,472","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-14","scope":"insider"},{"id":6444318,"accession":"0000899243-22-036916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-036916","line_url":"/filing/0000899243-22-036916#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III-A, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP L P; Column Group IV GP, LP; Column Group Opportunity III, LP; Column Group IV, LP; Column Group Opportunity III GP, LP","owner_display_name":"COLUMN GROUP III-A, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4330.0,"shares_display":"4,330","price_per_share":4.9991,"price_display":"5.00","price_state":"stated","total_value":21646.103,"total_display":"21,646.10","total_whole":"21,646","shares_owned_after":380172.0,"shares_owned_after_display":"380,172","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-23","scope":"insider"},{"id":6444315,"accession":"0000899243-22-036916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-036916","line_url":"/filing/0000899243-22-036916#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III-A, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP L P; Column Group IV GP, LP; Column Group Opportunity III, LP; Column Group IV, LP; Column Group Opportunity III GP, LP","owner_display_name":"COLUMN GROUP III-A, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35997.0,"shares_display":"35,997","price_per_share":4.9988,"price_display":"5.00","price_state":"stated","total_value":179941.8036,"total_display":"179,941.80","total_whole":"179,942","shares_owned_after":375842.0,"shares_owned_after_display":"375,842","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-23","scope":"insider"},{"id":6342383,"accession":"0000899243-22-035277","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-035277","line_url":"/filing/0000899243-22-035277#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III GP, LP; Column Group IV, LP; COLUMN GROUP III-A, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP","owner_display_name":"Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35058.0,"shares_display":"35,058","price_per_share":4.7156,"price_display":"4.72","price_state":"stated","total_value":165319.5048,"total_display":"165,319.50","total_whole":"165,320","shares_owned_after":339845.0,"shares_owned_after_display":"339,845","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-04","filed_date":"2022-11-07","scope":"insider"},{"id":6342379,"accession":"0000899243-22-035277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035277","line_url":"/filing/0000899243-22-035277#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III GP, LP; Column Group IV, LP; COLUMN GROUP III-A, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP","owner_display_name":"Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":104090.0,"shares_display":"104,090","price_per_share":4.9871,"price_display":"4.99","price_state":"stated","total_value":519107.239,"total_display":"519,107.24","total_whole":"519,107","shares_owned_after":304787.0,"shares_owned_after_display":"304,787","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-07","scope":"insider"},{"id":6945351,"accession":"0000899243-22-034562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034562","line_url":"/filing/0000899243-22-034562#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP L P; Column Group IV GP, LP; Column Group Opportunity III, LP; Column Group IV, LP; COLUMN GROUP GP, LP; COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP","owner_display_name":"TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76877.0,"shares_display":"76,877","price_per_share":4.8602,"price_display":"4.86","price_state":"stated","total_value":373637.5954,"total_display":"373,637.60","total_whole":"373,638","shares_owned_after":200697.0,"shares_owned_after_display":"200,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-27","filed_date":"2022-10-31","scope":"insider"},{"id":6741950,"accession":"0000899243-22-034359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-034359","line_url":"/filing/0000899243-22-034359#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group IV, LP; Column Group IV GP, LP; COLUMN GROUP L P; Column Group Opportunity III, LP","owner_display_name":"COLUMN GROUP III-A, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":72774.0,"shares_display":"72,774","price_per_share":4.8512,"price_display":"4.85","price_state":"stated","total_value":353041.2288,"total_display":"353,041.23","total_whole":"353,041","shares_owned_after":123820.0,"shares_owned_after_display":"123,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-27","scope":"insider"},{"id":6741947,"accession":"0000899243-22-034359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034359","line_url":"/filing/0000899243-22-034359#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group IV, LP; Column Group IV GP, LP; COLUMN GROUP L P; Column Group Opportunity III, LP","owner_display_name":"COLUMN GROUP III-A, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51046.0,"shares_display":"51,046","price_per_share":4.7484,"price_display":"4.75","price_state":"stated","total_value":242386.8264,"total_display":"242,386.83","total_whole":"242,387","shares_owned_after":51046.0,"shares_owned_after_display":"51,046","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-27","scope":"insider"},{"id":6089396,"accession":"0000899243-22-022214","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-022214","line_url":"/filing/0000899243-22-022214","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; TCG IV GP, LLC; Column Group IV GP, LP; COLUMN GROUP GP, LP; COLUMN GROUP III-A, LP; COLUMN GROUP L P","owner_display_name":"COLUMN GROUP III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":984161.0,"shares_display":"984,161","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":13286173.5,"total_display":"13,286,173.50","total_whole":"13,286,174","shares_owned_after":2650177.0,"shares_owned_after_display":"2,650,177","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-09","filed_date":"2022-06-13","scope":"insider","n_lines":2},{"id":6714216,"accession":"0000899243-22-021216","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-021216","line_url":"/filing/0000899243-22-021216","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III-A, LP; Column Group IV GP, LP; Column Group IV, LP; COLUMN GROUP L P; TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP","owner_display_name":"COLUMN GROUP III-A, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34200.0,"shares_display":"34,200","price_per_share":13.0333,"price_display":"13.03","price_state":"stated","total_value":445738.86,"total_display":"445,738.86","total_whole":"445,739","shares_owned_after":1698493.0,"shares_owned_after_display":"1,698,493","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-02","filed_date":"2022-06-06","scope":"insider","n_lines":2},{"id":6841021,"accession":"0000899243-22-020690","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-020690","line_url":"/filing/0000899243-22-020690","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; Column Group IV GP, LP; Column Group IV, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; TCG IV GP, LLC","owner_display_name":"COLUMN GROUP GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":92000.0,"shares_display":"92,000","price_per_share":13.45,"price_display":"13.45","price_state":"stated","total_value":1237400.0,"total_display":"1,237,400.00","total_whole":"1,237,400","shares_owned_after":1665422.0,"shares_owned_after_display":"1,665,422","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-01","filed_date":"2022-06-02","scope":"insider","n_lines":2},{"id":6841012,"accession":"0000899243-22-020690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-020690","line_url":"/filing/0000899243-22-020690","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; Column Group IV GP, LP; Column Group IV, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; TCG IV GP, LLC","owner_display_name":"COLUMN GROUP GP, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61806.0,"shares_display":"61,806","price_per_share":13.4658,"price_display":"13.47","price_state":"stated","total_value":832267.2348,"total_display":"832,267.23","total_whole":"832,267","shares_owned_after":1576458.0,"shares_owned_after_display":"1,576,458","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-06-02","scope":"insider","n_lines":2},{"id":6691316,"accession":"0000899243-22-020203","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-020203","line_url":"/filing/0000899243-22-020203","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; TCG IV GP, LLC; Column Group IV GP, LP; COLUMN GROUP GP, LP; Column Group IV, LP; COLUMN GROUP L P","owner_display_name":"COLUMN GROUP III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2710.0,"shares_display":"2,710","price_per_share":13.4513,"price_display":"13.45","price_state":"stated","total_value":36453.023,"total_display":"36,453.02","total_whole":"36,453","shares_owned_after":1516692.0,"shares_owned_after_display":"1,516,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider","n_lines":2},{"id":6691312,"accession":"0000899243-22-020203","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-020203","line_url":"/filing/0000899243-22-020203","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; TCG IV GP, LLC; Column Group IV GP, LP; COLUMN GROUP GP, LP; Column Group IV, LP; COLUMN GROUP L P","owner_display_name":"COLUMN GROUP III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20201.0,"shares_display":"20,201","price_per_share":13.4935,"price_display":"13.49","price_state":"stated","total_value":272582.1935,"total_display":"272,582.19","total_whole":"272,582","shares_owned_after":1514071.0,"shares_owned_after_display":"1,514,071","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-31","scope":"insider","n_lines":2},{"id":6532666,"accession":"0000899243-22-019940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019940","line_url":"/filing/0000899243-22-019940","is_derivative":false,"issuer_cik":"0001600420","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001600420","owner_cik":null,"owner_name":"Column Group IV-A, LP; Column Group IV, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP II, LP","owner_display_name":"Column Group IV-A, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":12.4549,"price_display":"12.45","price_state":"stated","total_value":23664.31,"total_display":"23,664.31","total_whole":"23,664","shares_owned_after":1236261.0,"shares_owned_after_display":"1,236,261","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-27","scope":"insider","n_lines":2},{"id":6318493,"accession":"0000899243-22-019690","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-019690","line_url":"/filing/0000899243-22-019690","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group IV, LP; COLUMN GROUP L P; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP","owner_display_name":"COLUMN GROUP III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43292.0,"shares_display":"43,292","price_per_share":13.4349,"price_display":"13.43","price_state":"stated","total_value":581623.6908,"total_display":"581,623.69","total_whole":"581,624","shares_owned_after":1494537.0,"shares_owned_after_display":"1,494,537","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-26","scope":"insider","n_lines":2},{"id":6318486,"accession":"0000899243-22-019690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019690","line_url":"/filing/0000899243-22-019690","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group IV, LP; COLUMN GROUP L P; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP","owner_display_name":"COLUMN GROUP III, LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17828.0,"shares_display":"17,828","price_per_share":13.368,"price_display":"13.37","price_state":"stated","total_value":238324.704,"total_display":"238,324.70","total_whole":"238,325","shares_owned_after":1452674.0,"shares_owned_after_display":"1,452,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-26","scope":"insider","n_lines":2},{"id":6235738,"accession":"0000899243-22-019471","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-019471","line_url":"/filing/0000899243-22-019471","is_derivative":false,"issuer_cik":"0001600420","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001600420","owner_cik":null,"owner_name":"Column Group IV, LP; Column Group IV-A, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP II, LP","owner_display_name":"Column Group IV, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16314.0,"shares_display":"16,314","price_per_share":12.0021,"price_display":"12.00","price_state":"stated","total_value":195802.2594,"total_display":"195,802.26","total_whole":"195,802","shares_owned_after":1234424.0,"shares_owned_after_display":"1,234,424","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-24","filed_date":"2022-05-25","scope":"insider","n_lines":2},{"id":6235725,"accession":"0000899243-22-019471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019471","line_url":"/filing/0000899243-22-019471","is_derivative":false,"issuer_cik":"0001600420","issuer_name":"RAPT Therapeutics, Inc.","issuer_ticker":"RAPT","issuer_name_source":null,"issuer_url":"/issuer/0001600420","owner_cik":null,"owner_name":"Column Group IV, LP; Column Group IV-A, LP; Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP II, LP","owner_display_name":"Column Group IV, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10236.0,"shares_display":"10,236","price_per_share":12.4993,"price_display":"12.50","price_state":"stated","total_value":127942.8348,"total_display":"127,942.83","total_whole":"127,943","shares_owned_after":1218648.0,"shares_owned_after_display":"1,218,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider","n_lines":2},{"id":6670156,"accession":"0000899243-22-019209","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-019209","line_url":"/filing/0000899243-22-019209","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP GP, LP; Column Group IV GP, LP","owner_display_name":"TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19034.0,"shares_display":"19,034","price_per_share":13.4776,"price_display":"13.48","price_state":"stated","total_value":256532.6384,"total_display":"256,532.64","total_whole":"256,533","shares_owned_after":1435434.0,"shares_owned_after_display":"1,435,434","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-23","scope":"insider","n_lines":2},{"id":6670153,"accession":"0000899243-22-019209","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-019209","line_url":"/filing/0000899243-22-019209","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP GP, LP; Column Group IV GP, LP","owner_display_name":"TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20666.0,"shares_display":"20,666","price_per_share":13.2547,"price_display":"13.25","price_state":"stated","total_value":273921.6302,"total_display":"273,921.63","total_whole":"273,922","shares_owned_after":1417028.0,"shares_owned_after_display":"1,417,028","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-23","scope":"insider","n_lines":2},{"id":6341701,"accession":"0000899243-22-018849","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-018849","line_url":"/filing/0000899243-22-018849","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; Column Group IV GP, LP","owner_display_name":"TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62650.0,"shares_display":"62,650","price_per_share":13.2039,"price_display":"13.20","price_state":"stated","total_value":827224.335,"total_display":"827,224.34","total_whole":"827,224","shares_owned_after":1397044.0,"shares_owned_after_display":"1,397,044","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-19","scope":"insider","n_lines":2},{"id":6341694,"accession":"0000899243-22-018849","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-018849","line_url":"/filing/0000899243-22-018849#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"TCG IV GP, LLC; COLUMN GROUP GP, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; Column Group IV GP, LP","owner_display_name":"TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":86110.0,"shares_display":"86,110","price_per_share":13.4171,"price_display":"13.42","price_state":"stated","total_value":1155346.481,"total_display":"1,155,346.48","total_whole":"1,155,346","shares_owned_after":1336461.0,"shares_owned_after_display":"1,336,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider"}],"collapsed":true,"next_cursor":"2022-05-17|6341694","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001861123","name":"Eikon Therapeutics, Inc.","url":"/issuer/0001861123","role":"Ten percent owner","n_filings":1,"first_seen":"2026-02-09","last_seen":"2026-02-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001426332","name":"NGM BIOPHARMACEUTICALS INC","url":"/issuer/0001426332","role":"Ten percent owner","n_filings":22,"first_seen":"2022-01-26","last_seen":"2023-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001673772","name":"RAPT Therapeutics, Inc.","url":"/issuer/0001673772","role":"Ten percent owner","n_filings":3,"first_seen":"2022-05-12","last_seen":"2022-05-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001796354","retrieved_at":"2026-08-23T05:23:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}